Estonia became the first country in the world to implement a nationwide Electronic Health Record system, creating a digital sandbox that has allowed a sophisticated health-tech ecosystem to flourish. Startups emerging from Tallinn and Tartu are leveraging two decades of longitudinal population data to create predictive and precision medicine tools. From using nanotechnology to heal wounds to applying AI to radiology, these companies are exporting the Estonian digital health standard to the rest of the world.
Here are the 10 Health-Tech startups in Estonia you need to watch in 2026.
Certific
Taavet Hinrikus, the co-founder of Wise, teamed up with Liis Narusk to launch Certific to decentralise medical diagnostics. The company provides a platform that enables fully certified remote medical testing, allowing patients to perform clinical-grade procedures from the comfort of their own homes. While they initially focused on streamlining COVID-19 certification, they have since pivoted to a broader “medical-grade remote care” infrastructure. Their technology validates the patient’s identity and the integrity of the test sample using computer vision and AI, ensuring that remote diagnostics are as reliable as a visit to a clinic.
Viveo Health
Raul Källo founded Viveo Health to fix the bottleneck in primary care access. The company operates a telemedicine ecosystem that bridges the gap between insurance and healthcare delivery. By integrating directly with employers and insurers, Viveo provides patients with instant access to doctors and digital prescriptions, bypassing the long wait times of the public system. They have expanded aggressively beyond the Baltics into markets such as Mexico and India, demonstrating that their model of rapid, digital-first triage can scale to serve millions of patients in developing healthcare infrastructures.
Antegenes
Dr Peeter Padrik established Antegenes to bring precision oncology to the mass market. The company uses polygenic risk scores (PRS) to estimate a patient’s genetic predisposition to common cancers, such as breast, prostate, and colorectal cancer. Unlike traditional genetic tests that look for single mutations, Antegenes analyses thousands of genetic variants to provide a personalised risk profile. This data enables doctors to create personalised screening plans, detecting cancer years earlier than standard protocols would. Their integration with the Estonian Biobank represents a pioneering shift toward preventative genetic medicine.
Better Medicine
Priit Salumaa built Better Medicine to act as a second pair of eyes for radiologists. The startup utilises deep learning to automate the segmentation of CT scans, with a specific focus on detecting metastatic cancer. Their AI models can identify and measure tumours across multiple organs in seconds, a task that is tedious and error-prone for human specialists. By reducing the time spent on image analysis, they allow radiologists to focus on complex diagnosis and treatment planning. The company is actively validating its technology with clinical partners across Europe to establish itself as a standard tool in oncology workflows.
Triumf Health
Dr Kadri Haljas created Triumf Health to support the mental well-being of children battling chronic illnesses. Their platform utilises gamification and psychology to help pediatric patients adhere to treatment plans and manage the stress associated with conditions like cancer or diabetes. The app functions as a digital therapeutic where children engage with an immersive story that teaches them coping mechanisms and health literacy. Clinical studies have shown that their approach significantly reduces depressive symptoms in patients, proving that mobile games can be a valid medical intervention.
Nanordica Medical
Spinning out of the National Institute of Chemical Physics and Biophysics, Nanordica Medical was co-founded by Dr Olesja Bondarenko to solve the crisis of antibiotic resistance. The company has developed a next-generation wound dressing that combines copper and silver nanoparticles to treat chronic wounds infected with bacteria. Their technology is significantly more effective than standard silver dressings in killing bacteria, including resistant strains such as MRSA. This deep-tech innovation addresses a massive problem for diabetic patients and the elderly, offering a physical solution that heals wounds which previously led to amputation.
Migrevention
Katrina Laks founded Migrevention after her own struggle with chronic migraines revealed a lack of specialised care. The company built the first fully digital headache clinic, connecting patients with neurologists, physiotherapists, and psychologists through a single app. Their platform enables users to track episodes and triggers, while also providing remote monitoring and digital therapy. By digitising the entire care pathway for migraine sufferers, they collect longitudinal data that helps clinicians optimise treatment plans and reduce the frequency of attacks for thousands of users.
Dermtest
Priit Kruus launched Dermtest to improve access to early melanoma detection. Their platform provides software for general practitioners and nurses to capture high-quality dermoscopic images of suspicious moles and send them to specialists for remote review and evaluation. This “teledermatoscopy” model enables patients in rural areas to get a diagnosis within 24 hours without needing to travel to a city specialist. They have expanded their toolkit to include psoriasis management and wound care documentation, thereby becoming the digital backbone for dermatology in primary care settings.
Velmio
Kristen Vagula developed Velmio to enhance maternal health outcomes through the use of AI. The pregnancy health app analyses lifestyle data from wearables and user inputs to predict potential complications like preeclampsia or gestational diabetes. Unlike generic pregnancy trackers, Velmio utilises machine learning to identify subtle patterns in a mother’s vital signs that may signal a risk. The goal is to empower expectant mothers with actionable insights that they can share with their doctors, shifting pregnancy care from reactive check-ups to proactive, continuous monitoring.
Cognuse
Andres Mellik founded Cognuse to focus on the rehabilitation and continuity of care for patients recovering from strokes and brain injuries. Their platform creates personalised digital rehabilitation plans that patients can follow at home or in the clinic. The interface is designed to be accessible for patients with cognitive impairments, using voice guidance and simplified visuals. By keeping patients engaged in their recovery process between doctor visits, Cognuse ensures better long-term functional outcomes and reduces the readmission rates for complex neurological conditions.